Treatment of a patient with acute myeloid leukemia with FLT3-ITD mutation

Katarzyna Jerzmanowska, Agnieszka Pluta

Vol 12, Supp. D (2021)

Case report

Effectiveness of combined therapy with midostaurin and standard chemotherapy and high dose chemotherapy with allogeneic stem cell transplantation in high risk acute myeloid leukemia with FLT3-TKD and NPM1 mutations

Elżbieta Patkowska, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Barbara Nasiłowska-Adamska

Vol 12, Supp. D (2021)

Case report

Midostaurin added to standard therapy in FLT3-positive acute myeloid leukemia treatment

Andrzej Szczepaniak, Zuzanna Rzetelska

Vol 12, Supp. D (2021)

Case report

Oral iron absorption test: myth or reality?

Samet Yaman, Yağmur Kınacı Gümüşçubuk, Oğuzcan Gümüşçubuk, Berkan Karabuğa, Sema Akinci, İmdat Dilek

Vol 14 (2023): Continuous Publishing

Research paper

Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients

Krzysztof Tomasiewicz, Alicja Dębska-Ślizień, Magdalena Durlik, Krzysztof Giannopoulos, Iwona Hus, Piotr Rutkowski

Vol 13, No 3-4 (2022)

Guidelines / Expert consensus

Ruxolitinib as a primary treatment for multiple myeloma in a patient with primary myelofibrosis? A case report and the review of the literature

Przemysław Zygmunciak, Justyna Iskrzak, Joanna Góra-Tybor, Ewa Lech-Marańda, Bartosz Puła

Vol 14 (2023): Continuous Publishing

Case report

Clinical and demographic characteristics of sickle cell disease in colombian children

Sara Maria Soto, Carlos Andres Portilla, Herney Andrés García-Perdomo

Vol 14 (2023): Continuous Publishing

Research paper

Incidence of lymphoid malignancies in patients with lymphocytosis identified by general practitioners

Marika Kasahara, Kajetan Karaszewski, Maria Król, Mateusz Ziarkiewicz, Wiesław Wiktor Jędrzejczak

Vol 14 (2023): Continuous Publishing

Letter to the Editor

Difficulties in the management of a patient with acute myeloid leukaemia and high mutant allelic ratio FLT3-ITD — refractoriness to the standard induction therapy along with midostaurin

Elżbieta Patkowska, Joanna Sawczuk-Chabin, Iwona Solarska, Katarzyna Borg, Ewa Lech-Marańda

Vol 12, Supp. D (2021)

Case report

Midostaurin in the treatment of patient with acute myeloid leukemia with FLT3-TKD mutation and NPM1 mutation

Aleksander Salomon-Perzyński, Urszula Walczak, Kinga Kos-Zakrzewska, Ewa Lech-Marańda, Bożena Katarzyna Budziszewska

Vol 12, Supp. D (2021)

Case report

Herpes zoster infections: epidemiology, diagnostics, and prophylaxis in light of a growing clinical problem

Paulina Własiuk, Krzysztof Giannopoulos

Vol 14 (2023): Continuous Publishing

Review paper

Introduction

Iwona Hus

Vol 12, Supp. D (2021)

Editorial

How to prevent sinusoidal obstruction syndrome/veno-occlusive disease?

Patrycja Mensah-Glanowska, Paulina Pyrcak, Anna Czyż

Vol 14 (2023): Continuous Publishing

Review paper

Bispecific antibodies in the treatment of follicular lymphoma

Aleksandra Bogucka-Fedorczuk, Tomasz Wróbel

Vol 14 (2023): Continuous Publishing

Review paper

Coexistence of chronic lymphocytic leukemia and NK/T lymphoma of the nasopharynx in a patient treated with ibrutinib

Aleksandra Rogowska, Agnieszka Końska, Monika Prochorec-Sobieszek, Bożena Katarzyna Budziszewska, Ewa Lech-Marańda, Bartosz Puła

Vol 14 (2023): Continuous Publishing

Case report